dunno jezza, Marc to me from recent comments seems intent on selling to big pharma in tranches so to speak....
Not selling EFTI hollus bollus but in different indications (out-licenced), with hefty royalties I hope,
whilst immutep keep researching EFTI in other more diverse fields with the aim of further out-licences down the track
as research matures, autoimmune wise, soft tissue (sarcoma) and indeed what ever else pops up...
dunno jezza, Marc to me from recent comments seems intent on...
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $591.1M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 42.5¢ | 41.0¢ | $58.64K | 139.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 18610 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 54852 | 13 |
View Market Depth
| Last trade - 11.06am 24/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |